Hims & Hers Health (NYSE:HIMS – Get Free Report) and Tivic Health Systems (NASDAQ:TIVC – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.
Insider & Institutional Ownership
63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 4.3% of Tivic Health Systems shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by insiders. Comparatively, 2.4% of Tivic Health Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Earnings & Valuation
This table compares Hims & Hers Health and Tivic Health Systems”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hims & Hers Health | $2.35 billion | 2.02 | $128.37 million | $0.51 | 40.76 |
| Tivic Health Systems | $780,000.00 | 2.24 | -$5.66 million | ($6.68) | -0.15 |
Hims & Hers Health has higher revenue and earnings than Tivic Health Systems. Tivic Health Systems is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Hims & Hers Health has a beta of 2.55, meaning that its stock price is 155% more volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500.
Profitability
This table compares Hims & Hers Health and Tivic Health Systems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hims & Hers Health | 5.47% | 22.48% | 7.02% |
| Tivic Health Systems | -1,557.26% | -202.20% | -173.34% |
Analyst Recommendations
This is a summary of current ratings for Hims & Hers Health and Tivic Health Systems, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hims & Hers Health | 1 | 13 | 3 | 0 | 2.12 |
| Tivic Health Systems | 1 | 0 | 0 | 0 | 1.00 |
Hims & Hers Health currently has a consensus price target of $31.29, suggesting a potential upside of 50.50%. Given Hims & Hers Health’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Hims & Hers Health is more favorable than Tivic Health Systems.
Summary
Hims & Hers Health beats Tivic Health Systems on 13 of the 14 factors compared between the two stocks.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
About Tivic Health Systems
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.
